Glucagon-like peptide 1 receptor agonists (GLP1RA)—medications for type 2 diabetes and obesity that have recently been making headlines due to a rise in popularity as weight loss agents—have ...
Maintaining muscle mass is crucial for health, and researchers have identified the protein BCL6 as vital for this. Studies ...
In a ginormous new study, researchers have begun mapping the manifold health benefits of drugs like Ozempic and Wegovy beyond ...
Pharmacists say they are aware of people being wrongly prescribed the drugs who have previously had eating disorders, or ...
Ozempic and Wegovy are increasingly available in Australia and worldwide to treat type 2 diabetes and obesity.
Hindustan Times on MSN22h
Doctor reacts to Oprah Winfrey’s comment on ‘thin people’: ‘Obesity rates aren’t rising globally because of willpower'Dr. Karan Rajan responds to Oprah Winfrey's insights on thin people, highlighting the complex biology behind obesity, beyond just willpower.
The rise of ultra-thin bodies in Hollywood, fueled by the popularity of weight loss medications, marks a dramatic shift in ...
New research highlights the potential of the protein BCL6 in preserving muscle mass, especially when used with popular weight ...
Weight loss drugs like Ozempic and Wegovy have been tied in a large, national study to a drop in the risk of developing ...
Tori Allen says she's thrilled to have lost 80 pounds since she went on Wegovy, one of the GLP-1 drugs that more and more people are using to treat diabetes or lose weight.
Novo Nordisk has reported topline outcomes from a Phase Ib/IIa trial of amycretin designed for treating obese or overweight ...
An observational analysis finds the drugs may lower the risk of substance abuse and cognitive issues. But the findings need clinical testing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback